<DOC>
	<DOCNO>NCT01372865</DOCNO>
	<brief_summary>The primary objective compare impact study formulation alergic rhinitis carrier .</brief_summary>
	<brief_title>A Clinical Trial About Treatment Mild Moderate Persistent Alergic Rhinnitis With Test Reference Mometasone ( PUMA )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Sign date inform consent form , case subject young 18 year , document must also sign legal guardian ; ≥ 12 year old ; Suffer mild moderate persistent alergic rhinitis ; Total NIS scale score ≥ 4 point screen visit within least 4 7 day randomization visit ; Indication use nasal corticosteroid ; Present alergic rhinitis symptom least 2 year ; May undergo washout period least 2 week Patients severe alergic rhinitis ; Patients severe comorbidities ( investigator 's criterion ) ; Patients mild severe persistent asthma ; Clinical history infection airways 30 day study entry ; Patients structural change cause nasal obstruction , pronounce nasal septum deviation , nasal polyp type nasal malformation ; For female subject , pregnant breastfeeding planning become pregnant unwilling use safe birth control method study ; subject need drug treat alergic rhinitis , antiimmunoglobulin E , immunotherapy , antileukotrienes , oral corticosteroid , inhalant corticosteroid , administration route cutaneous ; Active smoker ( use cigarette , pipe , cigar form tobacco amount within past 3 month study entry ) ; Participation another clinical study within past 12 month ;</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>